J Parent Enteral Nutr 1990
They also found that, even with higher GLP-1 levels, participants did not reduce their blood sugar levels more quickly
Risks and Side Effects Emerging Concerns in India 1
These products are often compared by consumers to prescription GLP-1 medications, but they are not FDA-approved drugs, are not clinically equivalent to GLP-1 receptor agonists, and ingredient-level research differs significantly from finished-product trials
The agency flagged claims about generic or clinically proven versions of approved GLP-1 therapies as potentially misbranded advertising in violation of the FDCA
Recalls & Warnings May 10, 2013 Maker of Concentration, Pain, Immune, Cholesterol Supplements Warned For Drug Claims On April 24, 2013, the FDA issued a warning letter to EuroPharma Co., Inc., following a review of the company's website which found statements made about Calm Kids, CholestCaps, CuraMed 375 mg, CuraMed 750 mg, Curamin, Mental Advantage, Tri-Iodine, and Viragen to be drug claims